WebJan 4, 2024 · Mar. 29, 2024 Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024 WebFeb 24, 2024 · In December 2024 Galmed announced an open-label trial (NCT04104321) to run concurrently with the double-blind trial that I was participating in. All participants in the open-label trial would receive the actual drug. Galmed stated that all participants in the double-blind trial would be given the option of transferring to the open-label trial.

Investors Center - Galmed Pharmaceuticals

WebMar 22, 2024 · On Thursday 04/13/2024 the closing price of the Galmed Pharmaceuticals Ltd. share was $0.32 on NAS. Compared to the opening price on Thursday 04/13/2024 on NAS of $0.31, this is a gain of 3.19%. WebOct 11, 2024 · The ARREST Phase 2b study randomized 247 patients with NASH confirmed by liver biopsy. Patients were randomized 2:2:1 to receive Aramchol 400mg, 600mg or placebo once daily. The manuscript ... la torche surf camp

Galmed Pharmaceuticals to Report Fourth Quarter and Year End …

WebJun 4, 2024 · Shares of GLMD have risen 5.8% in the past month. Analysts are bullish on the stock and the with a Strong Buy consensus rating based on 4 Buys. The average … WebMar 29, 2024 · Shareholders can obtain copies of Galmed's Annual Report on Form 20-F, free of charge, by making a request within a reasonable period of time to Galmed's Investor Relations Department at investor ... WebNov 2, 2011 · Dr. Gerald William Olmsted, MD is a health care provider primarily located in Spokane, WA. They have 57 years of experience. Their specialties include Plastic Surgery. la to reno by train